|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 7 871-879, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
ES Wijelath, B Carlsen, T Cole, J Chen, S Kothari and WP Hammond
Hope Heart Institute and Providence Medical Center, Department of Molecular Biology, Seattle, WA 98122, USA.
Oncostatin M (OSM), a pleiotropic cytokine originally isolated from supernatants of the U937 histiocytic lymphoma cell line, has been shown to have regulatory effects on a wide variety of cultured and tumor cells. We investigated the effects of OSM on basic fibroblast growth factor (bFGF) gene expression in bovine arterial endothelial (BAE) cells. Levels of bFGF mRNA transcripts were low in uninduced BAE cells, were maximal at 8 hours of exposure to OSM, and returned to control levels by 24 hours. Induction of bFGF mRNA transcripts by OSM was dose-dependent. Nuclear transcriptional run-on analysis demonstrated that exposure of BAE cells to OSM stimulated bFGF gene transcription. OSM treatment of BAE cells enhanced the synthesis of bFGF protein as determined by ELISA assays. Immunocytochemistry studies demonstrated the presence of low levels of bFGF protein within the cytoplasm in uninduced cells. After stimulation for 8 hours with OSM there was significant staining for bFGF in the cytoplasm. However, 24 hours after exposure to OSM, bFGF antigen was located only within the nuclei. Western blot analysis demonstrated that OSM stimulated predominantly the synthesis of a 22 kDa form of bFGF. In addition, OSM stimulated endothelial cell proliferation and migration as well as acquisition of a spindle shape. Phosphorothioate antisense oligonucleotide directed against bFGF inhibited OSM induced BAE cell proliferation and spindle shape formation but had only a minimal effect on migration. The levels of the 22 kDa form of bFGF were reduced by antisense treatment indicating that OSM induced proliferation and morphology change is likely to be regulated by intracellular bFGF. Our studies suggest that OSM released at sites of vascular injury could stimulate angiogenesis by inducing bFGF synthesis, endothelial cell proliferation and migration.
This article has been cited by other articles:
|
|
 |
|
  P. Sathyanarayana, M. P. Menon, O. Bogacheva, O. Bogachev, K. Niss, W. S. Kapelle, E. Houde, J. Fang, and D. M. Wojchowski Erythropoietin modulation of podocalyxin and a proposed erythroblast niche Blood, July 15, 2007; 110(2): 509 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cohen, S. Marchand-Adam, V. Lecon-Malas, J. Marchal-Somme, A. Boutten, G. Durand, B. Crestani, and M. Dehoux HGF synthesis in human lung fibroblasts is regulated by oncostatin M Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1097 - L1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Cocks, S. Thompson, F. E. Turner, A. Logan, J. A. Franklyn, J. C. Watkinson, and M. C. Eggo Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E460 - E469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagata, H. Kai, R. Shibata, M. Koga, A. Yoshimura, and T. Imaizumi Oncostatin M, an Interleukin-6 Family Cytokine, Upregulates Matrix Metalloproteinase-9 Through the Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase Pathway in Cultured Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 588 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Somasundaram, M. Ruehl, B. Schaefer, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan Interstitial Collagens I, III, and VI Sequester and Modulate the Multifunctional Cytokine Oncostatin M J. Biol. Chem., January 25, 2002; 277(5): 3242 - 3246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Giri and M. Ittmann Interleukin-8 Is a Paracrine Inducer of Fibroblast Growth Factor 2, a Stromal and Epithelial Growth Factor in Benign Prostatic Hyperplasia Am. J. Pathol., July 1, 2001; 159(1): 139 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishibe, G. Parry, A. Ishida, S. Aziz, J. Murray, Y. Patel, S. Rahman, K. Strand, K. Saito, Y. Saito, et al. Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation Blood, February 1, 2001; 97(3): 692 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta} Circ. Res., December 3, 1999; 85(12): 1124 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakayama, T. Hara, M. Hibi, T. Hirano, and A. Miyajima A Novel Oncostatin M-inducible Gene OIG37 Forms a Gene Family with MyD118 and GADD45 and Negatively Regulates Cell Growth J. Biol. Chem., August 27, 1999; 274(35): 24766 - 24772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria Oncostatin M Induces Angiogenesis In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1835 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ware, A Wells, and D. Lauffenburger Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner J. Cell Sci., January 8, 1998; 111(16): 2423 - 2432. [Abstract] [PDF]
|
|
